![Attreyi Mukherjee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Attreyi Mukherjee currently works as a Director at Impetis Biosciences Ltd.
Attreyi Mukherjee active positions
Companies | Position | Start |
---|---|---|
Impetis Biosciences Ltd.
![]() Impetis Biosciences Ltd. BiotechnologyHealth Technology Part of Tata Chemicals Ltd., Impetis Biosciences Ltd. is an IP focused drug discovery and licensing company founded in 2017. Impetis is headquartered in Mumbai, India, and seeks to license its assets to pharma companies for further development. The Indian company has developed therapeutic assets for autoimmune and inflammatory diseases, immuno-oncology, and Nonalcoholic steatohepatitis (NASH). The company's therapeutic assets include Receptor Activator (GRA), Bruton's Tyrosine Kinase Inhibitors (BTKi), ROR?t Inhibitor Program, GPR91 antagonists, and Adenosine receptor antagonists. The Board of Directors includes Mr. KRS Jamwal (Executive Director, Tata Industries), Mr. S. Sriram (CFO and Company Secretary, Tata Industries), and Attreyi Mukherjee (Senior Corporate Counsel, Tata Industries Ltd. & Director, Impetis Biosciences). | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Impetis Biosciences Ltd.
![]() Impetis Biosciences Ltd. BiotechnologyHealth Technology Part of Tata Chemicals Ltd., Impetis Biosciences Ltd. is an IP focused drug discovery and licensing company founded in 2017. Impetis is headquartered in Mumbai, India, and seeks to license its assets to pharma companies for further development. The Indian company has developed therapeutic assets for autoimmune and inflammatory diseases, immuno-oncology, and Nonalcoholic steatohepatitis (NASH). The company's therapeutic assets include Receptor Activator (GRA), Bruton's Tyrosine Kinase Inhibitors (BTKi), ROR?t Inhibitor Program, GPR91 antagonists, and Adenosine receptor antagonists. The Board of Directors includes Mr. KRS Jamwal (Executive Director, Tata Industries), Mr. S. Sriram (CFO and Company Secretary, Tata Industries), and Attreyi Mukherjee (Senior Corporate Counsel, Tata Industries Ltd. & Director, Impetis Biosciences). | Health Technology |
- Stock Market
- Insiders
- Attreyi Mukherjee